
Final 2-Year TELIGAN Data for Telitacicept in IgA Nephropathy
0:00
15:54
Welcome back to Kidney Compass!
Recording from ASN Kidney Week 2026 in Denver, Colorado, cohosts Brendon Neuen, MBBS, PhD, and Shikha Wadhwani, MD, MS, welcomed back Jicheng Lv, MD, of Peking University First Hospital, after he presented final 2-year results from the phase 3 TELIGAN trial during the late-breaking plenary.
More episodes from "Kidney Compass: Navigating Clinical Trials"



Don't miss an episode of “Kidney Compass: Navigating Clinical Trials” and subscribe to it in the GetPodcast app.








